30 Mar Submission of Post-Importation Testing Exemption requests for Biological and Biosimilar Medicines
Posted at 09:35h
in
As of the 1st of April 2022, the post-importation testing exemption requests for Biological and Biosimilar medicines should be submitted as per the requirements of Guideline 2.04. For submission process, please refer to section 3.0 Post-Importation Testing Exemptions (PITE).
2022 Mar
Download latest version
Version:
1
Date Updated:
24/03/2022
File Type:
pdf
Category:
Communication to industry